_edited.png)
OTC Sunscreen Monograph: How Sunscreens Are Regulated in the United States
- Daniel Jiménez
- 2 hours ago
- 4 min read
Unlike many other markets where sunscreens are regulated as cosmetics, in the U.S. they are legally classified as over-the-counter (OTC) drugs because they are intended to prevent sunburn and reduce the risk of skin cancer and premature skin aging caused by ultraviolet radiation.
This classification significantly impacts product development, labeling, testing, manufacturing, and market entry strategy.
Understanding how the FDA OTC sunscreen monograph works is essential for companies planning to commercialize sunscreen products in the United States.
Table of contents
Why Sunscreens Are Regulated as OTC Drugs in the U.S.
Under U.S. law, products intended to diagnose, cure, mitigate, treat, or prevent disease are considered drugs.
Because sunscreens are intended to prevent sunburn and protect against UV-induced skin damage, they fall within the drug category rather than cosmetics.
This means sunscreen products must comply with:
FDA drug regulations
OTC monograph requirements
Drug Good Manufacturing Practices (cGMP)
Drug labeling standards
Establishment registration and product listing
The regulatory burden is therefore significantly higher than for cosmetic products.
What Is the OTC Sunscreen Monograph?
The OTC sunscreen monograph is the regulatory framework that defines the conditions under which sunscreen products can be marketed in the United States without individual FDA product approval.
It specifies requirements related to:
Permitted active ingredients
Concentration limits
Dosage forms
SPF labeling
Broad spectrum claims
Required warnings and directions
Testing methods
Labeling structure
Products that comply with the monograph conditions are considered Generally Recognized as Safe and Effective (GRASE) and may be marketed without a New Drug Application (NDA).
Active Ingredients: GRASE vs Non-GRASE Categories
One of the most critical aspects of sunscreen regulation involves the status of active ingredients.
FDA has categorized sunscreen actives into different regulatory groups:
Ingredients considered GRASE
Ingredients requiring additional safety data
Ingredients not considered GRASE
Mineral UV filters such as zinc oxide and titanium dioxide are widely recognized as acceptable under current conditions.
Several organic UV filters require further safety evaluation before definitive classification.
Ingredient selection therefore plays a major role in regulatory strategy and product positioning.
Claims and Labeling Requirements
Sunscreen claims are tightly regulated in the United States because they relate directly to health protection.
Permitted claims depend on compliance with testing standards and monograph conditions.
The wording, placement, and formatting of these claims are highly controlled.
Unlike cosmetics, companies cannot freely develop marketing language outside monograph parameters.
Testing Requirements for Sunscreens
Demonstrating compliance with monograph conditions requires specific testing approaches.
These may include:
SPF testing
Broad spectrum testing
Water resistance testing
Stability data
Microbiological quality
Safety assessments
Companies often underestimate the technical complexity involved in generating acceptable data packages.
Testing must follow recognized methodologies and appropriate study design to support labeling claims.
Manufacturing Requirements: Drug GMP Compliance
Drug GMP standards are significantly more demanding than cosmetic GMP and typically require:
Validated manufacturing processes
Quality systems and documentation
Batch records and traceability
Laboratory controls
Change control systems
Complaint and recall procedures
Foreign manufacturers are also subject to FDA inspection authority.
FDA Registration and Listing Obligations
Companies marketing sunscreen products must complete several regulatory steps before commercialization.
These typically include:
Establishment registration with FDA
Product listing in FDA databases
NDC number assignment
Label compliance verification
Facility fee obligations under OMUFA
Although sunscreen products under the monograph do not require pre-approval, they are still subject to post-market oversight.
OMUFA Fees for Sunscreen Products
The Over-the-Counter Monograph User Fee Program (OMUFA) applies to facilities manufacturing OTC monograph drugs, including sunscreens.
Annual facility fees support FDA regulatory activities related to OTC oversight.
These fees apply to both domestic and foreign manufacturing sites and must be considered during financial planning.
The Role of the U.S. Agent for Foreign Companies
Foreign manufacturers of OTC sunscreen products must designate a U.S. Agent when registering with the FDA.
The U.S. Agent serves as the FDA’s domestic contact point and facilitates communication between the agency and the foreign establishment.
However, the U.S. Agent does not assume regulatory responsibility for compliance unless contractually defined.
Clarifying responsibilities between brand owners, manufacturers, and regulatory representatives is essential for successful market entry.
Strategic Considerations for International Sunscreen Brands
Companies entering the U.S. sunscreen market should consider several strategic factors:
Ingredient selection and regulatory status
Manufacturing capabilities and GMP readiness
Claims positioning and marketing strategy
Labeling design aligned with FDA requirements
Regulatory ownership (brand vs manufacturer)
Long-term portfolio expansion plans
Early regulatory planning can significantly reduce delays and compliance risks.
Common Challenges in U.S. Sunscreen Market Entry
Across international projects, several recurring challenges appear:
Assuming sunscreens are cosmetics rather than drugs
Using non-permitted active ingredients
Claims exceeding regulatory allowances
Underestimating testing complexity
Manufacturing sites not meeting drug GMP standards
Misalignment between brand owner and manufacturer responsibilities
These issues can delay market entry or create compliance exposure.
Why Regulatory Expertise Is Often Needed
Although the OTC monograph pathway avoids individual product approval, compliance still requires coordination across multiple regulatory areas:
Formulation and ingredient compliance
Testing and performance validation
Drug GMP manufacturing
Labeling and claims
FDA registration systems
Post-market obligations
Sunscreen regulation is therefore both technical and strategic.
Despite the fact that the FDA OTC sunscreen monograph provides a pathway for marketing sunscreen products in the US, the full compliance involves more than simply selecting approved ingredients. It requires alignment across formulation, testing, manufacturing, labeling, and regulatory systems.
Companies planning to enter the U.S. sunscreen market should approach regulatory strategy early to ensure efficient and compliant commercialization.
If your company is planning to commercialize sunscreen products in the United States or needs support navigating FDA OTC requirements, Belab Services can assist you.
Our regulatory specialists support international companies with:
Sunscreen regulatory strategy and classification
OTC monograph compliance assessment
FDA establishment registration and product listing
NDC assignment and labeling review
OMUFA compliance support
U.S. Agent services
End-to-end market entry strategy
Comments